Kbc Group Nv Fulgent Genetics, Inc. Transaction History

Kbc Group Nv

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$23.64 - $30.27 $19,479 - $24,942	-824 Reduced 54.07%	700 $20,000
Q3 2023 Feb 15, 2024	SELL	$26.74 - $40.81 $14,974 - $22,853	-560 Reduced 36.75%	964 $26,000
Q2 2023 Feb 15, 2024	SELL	$28.52 - $40.7 $5,276 - $7,529	-185 Reduced 10.83%	1,524 $56,000
Q2 2023 Jul 28, 2023	SELL	$28.52 - $40.7 $5,276 - $7,529	-185 Reduced 10.83%	1,524 $56,000
Q3 2022 Feb 15, 2024	BUY	$37.92 - $63.74 $38,261 - $64,313	1,009 Added 144.14%	1,709 $65,000
Q2 2022 Feb 14, 2024	SELL	$47.98 - $62.75 $78,975 - $103,286	-1,646 Reduced 49.06%	1,709 $93,000
Q2 2022 Jul 26, 2022	BUY	$47.98 - $62.75 $81,997 - $107,239	1,709 New	1,709 $93,000
Q1 2022 May 06, 2022	SELL	$49.85 - $96.11 $167,246 - $322,449	-3,355 Closed	0 $0
Q4 2021 Feb 14, 2024	BUY	$77.3 - $105.0 $205,231 - $278,775	2,655 Added 379.29%	3,355 $337,000
Q3 2021 Nov 10, 2021	SELL	$74.87 - $110.87 $22,985 - $34,037	-307 Reduced 8.38%	3,355 $302,000
Q2 2021 Aug 11, 2021	BUY	$66.8 - $100.45 $200,734 - $301,852	3,005 Added 457.38%	3,662 $338,000
Q1 2021 Apr 26, 2021	BUY	$59.3 - $183.85 $38,960 - $120,789	657 New	657 $63,000

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

Stay updated on Kbc Group Nv with notifications on news.